Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 101 results for "diovan hct"

Diovan generic floodgates open with FDA nods for Mylan, et al.

Novartis took its first big hit from new Diovan generics during last year's third quarter, when Ranbaxy Laboratories finally won approval for its exclusive generic of the blood pressure pill. And it was indeed a big hit: a 76% drop in U.S. sales for ... FiercePharma, 2 months ago
Creative Times

Research Report - Breast Cancer Therapeutics in Major Developed Market...

Summary GBI Research, the leading business intelligence provider, has released its latest research, Antihypertensive Therapeutics in Major Developed Markets to 2020 Increased Uptake of Combination Therapies to Offset Effects of Key Patent ...
 Creative Times2 weeks ago Market Overview - Antihypertensive Therapeutics in Major Developed Industry 2020: Radiant Insights, Inc  Press Release Ping2 weeks ago Cardiovascular Drugs Market - Global Industry Size, Share, Trends Analysis to 2020  Digital Journal2 weeks ago Antihypertensive Therapeutics in Major Developed Market Size, Share, Trends Analysis...  Creative Times2 weeks ago

Valsartan - 2015 Comprehensive Patent Search

Research and Markets (http://www.researchandmarkets.com/research/vzs98b/valsartan) has announced the addition of the "Valsartan - Comprehensive patent search" report to their offering. Imagine having your own team of pharmaceutical patent experts at ...
 Individual.com1 month ago Research and Markets: Valsartan - 2015 Comprehensive Patent Search  TeleTrader.com4 weeks ago
[x]  

Method and system for forming a pharmaceutical product directly onto a packaging surface

The present invention relates to a method for forming a pharmaceutical product, such as a dissolvable film dosage form, onto a surface. Particularly, the present invention relates to a method of forming a pharmaceutical product directly onto the ...
 PharmCast1 month ago

Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog

Novartis A.G . ( NVS ) reported fourth-quarter 2014 earnings of 62 cents per share, down 23% from the year-ago period. Core earnings per share came in at $1.21, up from $1.18 in the year-ago period and beat the Zacks Consensus Estimate of $1.13.
 Zacks.com1 month ago
EuroInvestor

Novartis a enregistré en 2014 une forte augmentation de ses ventes, sa marge et progrès de son pipeline; la transformation du portefeuille concentrera l'entreprise sur ses principales activités - HTML (w)

Company : NOVARTIS Compartment : Other ISIN : CH0012005267 Wire : Thomson Reuters ONE Document type : Permanent Information Releases / General Company News Publication date : 1/27/2015 7:00:00 AM ...
 WorldRegInfo2 months ago Novartis : delivered solid sales growth, margin expansion and pipeline progress in 2014; portfolio transformation will focus company on leading businesses  4 Traders2 months ago Novartis delivered solid sales growth, margin expansion and pipeline progress in 2014; portfolio transformation will focus company on leading businesses  Sante Log2 months ago REG-Novartis delivered solid sales growth, margin expansion and pipeline progress in 2014; portfolio transformation will focus company on leading businesses  Reuters2 months ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less